MedTrace Logo

A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary Care

NCT01121315 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58326

Last updated 2012-05-11

No results posted yet for this study

Summary

To describe the type II diabetes population in primary care with special reference to treatment, other diseases and mortality during the last decade. To test the hypothesis that the type or combination of per oral glucose lowering drugs have different effects on the risk of cardiovascular disease and diabetic complications.

Conditions

  • Diabetes Type II

Sponsors & Collaborators

Principal Investigators

  • Leif Lohm, MD · AstraZeneca Nordic, Södertälje

  • Gunnar Johansson, MD · Uppsala University, Sweden

  • Carl Johan Östgren, MD · Ödeshögs VC

  • Johan Sundström, MD PhD · Uppsala University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01121315 on ClinicalTrials.gov